GLUCOSEREADY
Live / Registered — Registered (as of 05 May 2026)
What this means for you
Registered since 05 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 May 2032: the §8 declaration of use).
Record
- Serial number
- 98359296
- Registration number
- 8244034
- Mark type
- Word mark
- Filed
- 16 Jan 2024
- Published for opposition
- 01 Oct 2024
- Registered
- 05 May 2026
- Next maintenance filing
- §8 declaration of use, due by 05 May 2032 (grace period to 05 Nov 2032)
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable software for collecting medical data
- Class 042 — Scientific and technological services: Software-as-a-Service services featuring software for collecting, accessing and exporting patient medical data; providing online non-downloadable software for collecting, accessing and exporting patient medical data; providing temporary use of a nondownloadable web application for collecting, accessing and exporting patient medical data
Owner
- Clinical Ink, Inc., Winston-Salem, NC, US
- Clinical Ink, Inc., Winston-Salem, NC, US
- Clinical Ink, Inc., Winston-Salem, NC, US
Prosecution history
- 05 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2026 — ASSIGNED TO LIE
- 31 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — NON-FINAL ACTION E-MAILED
- 06 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 23 Nov 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2025 — USE AMENDMENT FILED
- 23 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED